Cue Biopharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cue Biopharma and other ETFs, options, and stocks.About CUE
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series (autoimmune diseases), CUE-500 series (targeted cell depletion), and CUE-100 series (Oncology).
CUE Key Statistics
Stock Snapshot
With a market cap of 123.07M, Cue Biopharma(CUE) trades at $29.30. The stock has a price-to-earnings ratio of -5.26.
On 2026-06-09, Cue Biopharma(CUE) stock moved within a range of $27.93 to $31.52. With shares now at $29.30, the stock is trading +4.9% above its intraday low and -7.0% below the session's peak.
Trading volume for Cue Biopharma(CUE) stock has reached 13.29K, versus its average volume of 82.27K.
Over the past 52 weeks, Cue Biopharma(CUE) stock has traded between a high of $41.42 and a low of $4.97.
Over the past 52 weeks, Cue Biopharma(CUE) stock has traded between a high of $41.42 and a low of $4.97.
CUE News
Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...
Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...
Cue Biopharma (CUE) announced the transition of its board as the company advances its strategic growth and development efforts. Effective May 29, four independe...
More CUE News
...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.